A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Amprenavir

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (9)

10011

Saint Vincent's AIDS Ctr, New York

20037

Dr Bruce Rashbaum, Washington D.C.

32751

Community Research Initiative of Central Florida, Maitland

33136

Univ of Miami School of Medicine, Miami

33146

Community Research Initiative of South Florida, Coral Gables

38104

Methodist Hosp, Memphis

60610

Chicago Ctr for Clinical Research, Chicago

90211

Pacific Oaks Research, Beverly Hills

02445

Community Research Initiative of New England, Brookline

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002195 - A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients | Biotech Hunter | Biotech Hunter